Variant report

Variant	esv3360675
Chromosome Location	chr21:46010349-46012897
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:37)
CpG islands
(count:122)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:37 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr21:46011829-46011886	GM13977	blood:	n/a	n/a
2	CTCF	chr21:46011780-46011930	SK-N-SH_RA	brain:	n/a	n/a
3	CTCF	chr21:46011860-46012010	GM12873	blood:	n/a	n/a
4	CTCF	chr21:46011653-46011739	MCF-7	breast:	n/a	n/a
5	CTCF	chr21:46011660-46011810	NHEK	skin:	n/a	n/a
6	CTCF	chr21:46011663-46011673	MCF-7	breast:	n/a	n/a
7	CTCF	chr21:46011675-46011721	MCF-7	breast:	n/a	n/a
8	CTCF	chr21:46011804-46011986	LNCaP	prostate:	n/a	n/a
9	CTCF	chr21:46011373-46011427	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTCF	chr21:46011540-46011690	HepG2	liver:	n/a	n/a
11	CTCF	chr21:46011860-46012010	HEK293	kidney:	n/a	n/a
12	CTCF	chr21:46011520-46011670	HMEC	breast:	n/a	n/a
13	CTCF	chr21:46011880-46012030	Hela-S3	cervix:	n/a	n/a
14	CTCF	chr21:46011580-46011730	WERI-Rb-1	eye:	n/a	n/a
15	CTCF	chr21:46011821-46011882	LNCaP	prostate:	n/a	n/a
16	CTCF	chr21:46011880-46012030	HepG2	liver:	n/a	n/a
17	CTCF	chr21:46012078-46012141	LNCaP	prostate:	n/a	n/a
18	CTCF	chr21:46011847-46011889	Lung_OC	lung:	n/a	n/a
19	CTCF	chr21:46011840-46011990	NHEK	skin:	n/a	n/a
20	CTCF	chr21:46011393-46011442	MCF-7	breast:	n/a	n/a
21	CTCF	chr21:46011407-46011464	NHEK	skin:	n/a	n/a
22	EBF1	chr21:46011636-46011996	GM12878	blood:	n/a	n/a
23	HEY1	chr21:46011668-46011863	K562	blood:	n/a	n/a
24	MAX	chr21:46012710-46012749	NB4	blood:	n/a	n/a
25	MYC	chr21:46011317-46011500	MCF-7	breast:	n/a	n/a
26	MYC	chr21:46011313-46011314	MCF-7	breast:	n/a	n/a
27	PBX3	chr21:46011669-46011848	GM12878	blood:	n/a	n/a
28	PBX3	chr21:46011851-46011974	GM12878	blood:	n/a	n/a
29	PBX3	chr21:46012010-46012150	GM12878	blood:	n/a	n/a
30	POLR2A	chr21:46011812-46012204	H1-hESC	embryonic stem cell:	n/a	n/a
31	REST	chr21:46011234-46012348	PANC-1	pancreas:	n/a	n/a
32	REST	chr21:46011445-46012195	SK-N-SH	brain:	n/a	n/a
33	SIX5	chr21:46011631-46011875	K562	blood:	n/a	n/a
34	TCF12	chr21:46012275-46012963	ECC-1	luminal epithelium:	n/a	chr21:46012677-46012687
35	TCF3	chr21:46011995-46012239	GM12878	blood:	n/a	n/a
36	USF1	chr21:46011204-46011403	HepG2	liver:	n/a	n/a
37	YY1	chr21:46012306-46012726	ECC-1	luminal epithelium:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr21:46011329-46011379	GM19239	blood:	n/a
2	chr21:46011329-46011379	AG04450	lung:	fetal
3	chr21:46012520-46012570	Jurkat	blood:	n/a
4	chr21:46011329-46011379	NT2-D1	testis:	n/a
5	chr21:46011329-46011379	BJ	skin:	n/a
6	chr21:46012520-46012570	HAEpiC	amniotic membrane:	n/a
7	chr21:46012520-46012570	SAEC	small airway:	n/a
8	chr21:46011329-46011379	LNCaP	prostate:	n/a
9	chr21:46012520-46012570	NB4	blood:	n/a
10	chr21:46012520-46012570	U87	brain:	n/a
11	chr21:46011329-46011379	GM12891	blood:	n/a
12	chr21:46011329-46011379	HAEpiC	amniotic membrane:	n/a
13	chr21:46012520-46012570	NT2-D1	testis:	n/a
14	chr21:46011329-46011379	H1-hESC	embryonic stem cell:	embryo
15	chr21:46011329-46011379	PANC-1	pancreas:	n/a
16	chr21:46011329-46011379	NH-A	brain:	n/a
17	chr21:46012520-46012570	ECC-1	luminal epithelium:	n/a
18	chr21:46011329-46011379	T-47D	breast:	n/a
19	chr21:46011329-46011379	RPTEC	kidney:	n/a
20	chr21:46012520-46012570	A549	lung:	n/a
21	chr21:46012520-46012570	HPAEpiC	pulmonary alveolar:	n/a
22	chr21:46012520-46012570	NHDF-neo	bronchial:	n/a
23	chr21:46011329-46011379	MCF-7	breast:	n/a
24	chr21:46011329-46011379	Caco-2	colon:	n/a
25	chr21:46012520-46012570	AG09319	gingival:	n/a
26	chr21:46012520-46012570	PANC-1	pancreas:	n/a
27	chr21:46012520-46012570	LNCaP	prostate:	n/a
28	chr21:46012520-46012570	PFSK-1	brain:	n/a
29	chr21:46012520-46012570	BJ	skin:	n/a
30	chr21:46012520-46012570	SK-N-SH_RA	brain:	n/a
31	chr21:46011329-46011379	MCF10A-Er-Src	breast:	n/a
32	chr21:46012520-46012570	AG04449	skin:	fetal
33	chr21:46011329-46011379	HL-60	blood:	n/a
34	chr21:46012520-46012570	GM19239	blood:	n/a
35	chr21:46012520-46012570	Hela-S3	cervix:	n/a
36	chr21:46012520-46012570	HRPEpiC	eye:	n/a
37	chr21:46012520-46012570	RPTEC	kidney:	n/a
38	chr21:46011329-46011379	BE2_C	brain:	n/a
39	chr21:46012520-46012570	AG09309	skin:	n/a
40	chr21:46011329-46011379	SK-N-SH	brain:	n/a
41	chr21:46011329-46011379	NB4	blood:	n/a
42	chr21:46011329-46011379	SK-N-MC	brain:	n/a
43	chr21:46011329-46011379	HCPEpiC	choroid plexus:	n/a
44	chr21:46011329-46011379	NHDF-neo	bronchial:	n/a
45	chr21:46011329-46011379	AG10803	skin:	n/a
46	chr21:46011329-46011379	HEEpiC	esophagus:	n/a
47	chr21:46012520-46012570	T-47D	breast:	n/a
48	chr21:46012520-46012570	CMK	blood:	n/a
49	chr21:46011329-46011379	HCM	heart:	n/a
50	chr21:46011329-46011379	HIPEpiC	eye:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr21:46001819..46004380-chr21:46009202..46011051,3	K562	blood:
2	chr21:46010036..46012728-chr21:46031362..46034012,2	MCF-7	breast:

No data

Variant related genes	Relation type
KRTAP10-6	TF binding region
KRTAP10-6	CpG island
ENSG00000187766	chromatin interactions

Extended variants
information (count: 252 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:252 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs587663328	chr21:46010352-46010353	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs587742904	chr21:46010385-46010386	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs56188080	chr21:46010386-46010387	Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs587689387	chr21:46010391-46010392	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs116776594	chr21:46010392-46010393	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs587618776	chr21:46010413-46010414	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs151215294	chr21:46010429-46010430	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs114480957	chr21:46010464-46010465	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs233297	chr21:46010467-46010468	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs587678385	chr21:46010471-46010472	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs587733920	chr21:46010476-46010477	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs587775658	chr21:46010486-46010487	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs587644127	chr21:46010506-46010507	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs397834518	chr21:46010514-46010515	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs587717681	chr21:46010533-46010534	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs181342131	chr21:46010586-46010587	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs447082	chr21:46010592-46010593	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs587710145	chr21:46010600-46010601	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs114521859	chr21:46010602-46010603	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs587663085	chr21:46010615-46010616	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs140396472	chr21:46010637-46010638	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs587610033	chr21:46010648-46010649	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs186962783	chr21:46010649-46010650	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs397834519	chr21:46010654-46010655	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs144476867	chr21:46010655-46010656	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs397834520	chr21:46010671-46010672	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs587722047	chr21:46010679-46010680	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs191401352	chr21:46010680-46010681	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs587723727	chr21:46010684-46010685	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs181998721	chr21:46010712-46010713	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs1211081	chr21:46010735-46010736	Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs587654028	chr21:46010756-46010757	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs587709391	chr21:46010778-46010779	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs587767147	chr21:46010799-46010800	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs386819181	chr21:46010806-46010807	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs73907036	chr21:46010807-46010808	Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs587748721	chr21:46010815-46010816	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs13047287	chr21:46010831-46010832	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs13046867	chr21:46010835-46010836	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs587651226	chr21:46010840-46010841	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs371496295	chr21:46010860-46010861	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs373437564	chr21:46010863-46010864	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs587607831	chr21:46010864-46010865	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs142113760	chr21:46010902-46010903	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs587638638	chr21:46010903-46010904	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs187036996	chr21:46010912-46010913	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs587594198	chr21:46010961-46010962	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs587663596	chr21:46010962-46010963	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs587747758	chr21:46010979-46010980	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs233298	chr21:46010984-46010985	Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	18628472	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Ewing''s sarcoma	21437220	CNVD
Lung adenocarcinoma	17086460	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute myeloid leukemia	21358987	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	23341502	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Ewing''s sarcoma	18628472	CNVD
Leukemia	18628472	CNVD
small cell lung cancer	17426248	CNVD
Developmental delay	21147756	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Bipolar disorder	19114987	CNVD

Chromatin state (count:52 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:45998800-46012800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr21:46000200-46011400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr21:46002400-46018200	Weak transcription	Right Atrium	heart
4	chr21:46010200-46012400	Weak transcription	HUES6 Cell Line	embryonic stem cell
5	chr21:46010400-46010600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
6	chr21:46011000-46011200	Enhancers	H1 Cell Line	embryonic stem cell
7	chr21:46011000-46011600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
8	chr21:46011000-46012200	Enhancers	Fetal Muscle Trunk	muscle
9	chr21:46011000-46012600	Enhancers	Fetal Muscle Leg	muscle
10	chr21:46011200-46011600	ZNF genes & repeats	Spleen	Spleen
11	chr21:46011200-46013200	Enhancers	HepG2	liver
12	chr21:46011400-46011600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
13	chr21:46011400-46011600	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
14	chr21:46011400-46011600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
15	chr21:46011400-46011600	Bivalent Enhancer	Colonic Mucosa	Colon
16	chr21:46011400-46011600	Enhancers	Placenta	Placenta
17	chr21:46011400-46011800	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
18	chr21:46011400-46012000	Bivalent Enhancer	Adipose Nuclei	Adipose
19	chr21:46011400-46012600	Weak transcription	H1 Cell Line	embryonic stem cell
20	chr21:46011400-46014000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr21:46011400-46014000	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
22	chr21:46011400-46014400	Enhancers	Liver	Liver
23	chr21:46011600-46011800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
24	chr21:46011600-46011800	Enhancers	HMEC	breast
25	chr21:46011600-46012200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
26	chr21:46011600-46012200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
27	chr21:46011600-46012400	Weak transcription	Spleen	Spleen
28	chr21:46011600-46013000	Enhancers	Esophagus	oesophagus
29	chr21:46012000-46013400	Weak transcription	HMEC	breast
30	chr21:46012200-46014000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr21:46012200-46014000	Enhancers	Placenta	Placenta
32	chr21:46012200-46014200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
33	chr21:46012200-46014400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
34	chr21:46012400-46012800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr21:46012400-46012800	Enhancers	Spleen	Spleen
36	chr21:46012400-46013600	Bivalent Enhancer	Fetal Stomach	stomach
37	chr21:46012400-46014600	Enhancers	HUES6 Cell Line	embryonic stem cell
38	chr21:46012600-46012800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
39	chr21:46012600-46013000	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
40	chr21:46012600-46013000	Enhancers	K562	blood
41	chr21:46012600-46014000	Enhancers	ES-I3 Cell Line	embryonic stem cell
42	chr21:46012600-46014200	Enhancers	iPS-18 Cell Line	embryonic stem cell
43	chr21:46012600-46014200	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
44	chr21:46012600-46014400	Bivalent Enhancer	Fetal Muscle Leg	muscle
45	chr21:46012600-46014600	Enhancers	H1 Cell Line	embryonic stem cell
46	chr21:46012800-46013400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
47	chr21:46012800-46013400	Bivalent Enhancer	Adipose Nuclei	Adipose
48	chr21:46012800-46013600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
49	chr21:46012800-46013600	Enhancers	H9 Cell Line	embryonic stem cell
50	chr21:46012800-46013800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links